Company page

Nuvation Bio Inc.

Nuvation Bio Inc. is a public company traded under the ticker NUVB in the American market. The company has a market capitalization of approximately $2.24 billion. Nuvation Bio focuses on developing innovative therapies to improve patient outcomes.

NUVB:NYSEUpdated August 28, 2026
Nuvation Bio Inc. logo
Ticker
NUVB:NYSE
Asset type
Stock
Market cap
$2.35B
Sector
Health Technology
Industry
Biotechnology
Exchange
NYSE
Currency
USD